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ABSTRACT 
Introduction: Nontuberculous recurrent cough is becoming rampant among hospitalized patients.  
Aim: Hospitalized patients and out-patients in some hospitals in Cross River State were studied for the prevalence of non-
tuberculous recurrent cough in the state 
Methods: This was carried out using standard procedures in Microbiology.  
Results: The bacterial isolates from the sputum samples were Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus 
pyogenes, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, and Corynebacterium diphtheriae. The patients’ age 
group 20 – 39 years had the highest prevalence of non – tuberculous recurrent cough (46.7%) while the least prevalence of 1.0% 
was among the age group ≥ 80 years. The prevalence rate of 33.7% was the highest among the social class and businessmen, 
while the least prevalence rate of 8.2% was found among students. Out of a total of 1466 samples studied, 93.6% was non- 
tuberculous cases.  
Conclusion: Mycobacterium tuberculosis is therefore not the predominant cause of cough in the study area as at the time of this 
study 
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RÉSUMÉ 
Introduction: La toux récurrente non devient monnaie courante chez les patients hospitalisés. Objectif : les patients hospitalisés 
et les patients externes dans certains hôpitaux dans l'État de Cross River ont été étudiés pour la prévalence de la toux récurrente 
non tuberculeuse dans l'état 
Méthodes: Il a été réalisé à l'aide de procédures standard en microbiologie. 
Résultats: Les isolats bactériens de l'échantillons d'expectoration étaient Staphylococcus aureus, Streptococcus pneumoniae, 
Streptococcus pyogenes, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, et de Corynebacterium diphtheriae. 
Le patients' le groupe d'âge 20 - 39 ans ont la plus forte prévalence de non - toux récurrentes tuberculeuse (46,7  %) tandis que la 
prévalence de moins de 1,0  % a été parmi le groupe d'âge de moins de 80 ans. .                                                                                                
Copyright ©2017 AJCEM. This work is licensed under the Creative Commons Attribution 4.0 International License CC-BY 
269 
 
Le taux de prévalence de 33,7  % a été le plus élevé parmi les classes sociales et d'affaires, alors que les taux de prévalence de 
8,2 % a été constaté chez les élèves. Sur un total de 1466 échantillons étudiés, 93,6  % des cas non tuberculeuse -.  
Conclusion: Mycobacterium tuberculosis n'est donc pas la principale cause de la toux dans la zone d'étude au moment de l'étude 
Mots clés: non-tuberculose, toux récurrentes, Mycobacterium tuberculosis, Ziehl-Neelsen 
 
INTRODUCTION                                                                            
Some reflex actions are evidence that pathogens or 
pollen had gained entrance into the body and such 
action (s) is/are meant to eliminate the non-self 
component and excessive mucus. Cough is an 
example of such sudden mechanical action. It is 
controlled by same contraction of muscles that control 
breathing [1,2] and it expels deoxygenated 
contaminated air from the lungs. Coughing, a reflex 
response of the body caused by an irritation in the 
throat or windpipe, participate in protecting the 
delicate lung tissue from pathogens and other 
substances [2-4]. Apart from the need to eliminate 
infections, other causes of cough include allergies and 
cancer.  
Cough can be acute, sub-acute or chronic5. Acute 
cough lasts for a short period of time not exceeding 
21days. It is usually due to viral infection or bacterial 
infection of the upper respiratory tract infections 
(URTI) among others [2]. As soon as the infection 
being cleared is eliminated, acute cough seizes. So, it 
is usually transient.  Chronic cough may be caused by 
a variety of underlying diseases including asthma, 
cystic fibrosis, allergies, gastroesophageal reflux 
disease (GERD), and chronic postnasal drip [6,7]. A 
cough may be productive or dry. A productive cough 
brings up mucus while a dry cough does not. Dry 
cough may result from a viral illness and may last up 
to several weeks. Children with pneumonia can 
appear sick with fever and a mild cough or be very ill 
with high fever and laboured breathing [8]. 
Pneumonia is caused either by viruses or bacteria. For 
proper diagnosis of cough, information regarding the 
duration of cough, other symptoms that may 
accompany it and the environmental factors that may 
influence it are very useful. The treatment of cough, 
like other symptoms depends highly on the severity 
and underlying cause of the cough. Acute cough like 
pneumonia may require antibiotics. Anti-tussives 
suppress a cough. Cough suppressants may lessen 
cough while dextromethorphan depresses the brain’s 
cough centre. 
Non – tuberculous Mycobacteria (NTM) have 
emerged as important opportunistic pathogen of the 
human being in recent years. They are ubiquitous as 
environmental organisms that sometimes cause 
respiratory disease usually in patients with pre-
existing pulmonary damage [9]. Mycobacterial 
studies have been conducted on the citizens in South 
Africa [10, 11]. On one of such studies, the sputum 
from 1,196 Zulus in Natal, South Africa, the presence 
of mycobacteria was assessed10 without recourse to 
clinical information. A NTM  prevalence rates of 
colonization/infection was 1,400/100,000.  
A similar research among patients with lower 
respiratory infection in Chest Clinic in Lagos, Nigeria 
showed the screening of six hundred and sixty eight 
ramdomly for pulmonary tuberculosis [12]. An 
observation of 11% NTM prevalence was made.  
Information on NTM or non tuberculous recurrent 
cough in the study location was rare to the best of our 
knowledge. This study therefore was aimed at 
assessing the prevalence of non tuberculous recurrent 
cough in patients with recurrent cough in Cross River 
State, Nigeria.  
MATERIAL AND METHODS                                                                   
Sources and Collection of Samples 
One thousand four hundred and sixty six sputa were 
collected from both in – patients and out – patients in 
hospitals with recurrent and productive cough in 
Cross River State. The study was carried out from 
January to October 2009 (10 months). Sputum from 
each patient was collected into a sterile universal 
bottle in the hospital and transported to the 
laboratory for analysis within 2 hours of collection. 
The hospitals studied represent different 
community/locations. The referral hospitals include 
Infectious Disease Hospital, Ogoja (IDHO), General 
Hospital, Ugep (GHU), General Hospital, Calabar 
(GHC), General Hospital, Obudu (GHB), General 
Hospital, Ikom, (GHI), General Hospital, Akamkpa 
(GHA), and General Hospital, Ogoja (GHO).  The 
research was done without violating the ethical 
standards and the patients’ right. 
Processing Of Samples for Microscopic Examination 
Ziehl Neelsen staining technique was used to stain 
each of the sputum samples to isolate samples which 
contained acid – fast bacilli (AFB) [13-17]. 
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Sputum culture and Identification of bacteria 
A sterile wire loop was used to aseptically inoculate 
each of the sputum samples on Blood agar, 
MacConkey agar and Chocolate agar for microbial 
morphology and identification. The seeded plates 
were then incubated. Blood agar and McConkey agar 
plates were incubated aerobically at 37oC for 24 hours 
while chocolate agar plates were incubated in a 
carbon (IV) oxide enriched atmosphere at 37oC for 24 
hours. All the isolates were purified by sub-culturing. 
The pure culture of the isolate were characterized and 
identified using colonial morphology, Gram’s 
staining, microscopic examination, biochemical tests 
and sugar ferment action profile. Biochemical tests 
carried out were coagulase, oxidase, catalase, citrate, 
urease, bile solubility, indole, Voges-Proskauer, 
methyl red, nitrate reduction, motility, and spore tests 
[18-20]. 
Statistical Analysis: The results were statistically 
analyzed using ANOVA with the p>0.05 
RESULTS AND DISCUSSION  
Out of the 1466 samples studied, five hundred and 
forty eight (37.4%) samples were collected from 
Infectious Disease Hospital, Ogoja; 169 (11.2%) were 
collected from General Hospital, Calabar, 120 (8.2%) 
from General Hospital, Ogoja; 126 (8.6%) from 
General Hospital, Ugep; 250 (17.1%) from General 
Hospital, Ikom; 189 (12.9%) from General Hospital, 
Obudu and 64 (4.4%) of the samples were collected 
from General Hospital, Akamkpa. 1372  (93.6%) were 
AFB-negative while 94 (6.4%) were AFB positive. The 
hospital which had the highest no of TB patients was 
infectious Disease Hospital, Ogoja with the 
prevalence of 532 (97.1%) out of 548 tested; followed 
by General Hospital, Ugep with the rate of 122 
(96.8%) out of 126 screened, then General Hospital, 
Calabar 158 (93.5%) out of 169 screened, General 
Hospital, Obudu 178 (93.1%) out of 189 studied, 
General Hospital, Ogoja 110 (91.7%) out of 120 
sampled, General Hospital, Akamkpa 56  (87.5%) out 
of 64 screened, while General Hospital, Ikom had the 
least prevalence 218 (87.2%) (Table1). Results of social 
class prevalence revealed that businessmen were the 
most affected group with the prevalence of 33.7%, 
followed by farmers with the rate of 28.5%; 
public/civil servants had the prevalence of 19.8% 
while dependents had 9.9% prevalence. However, 
students recorded the least prevalence of 8.2% (Table 
2).  
The age prevalence results revealed that adults aged 
20 – 39 years had the prevalence of 46.7% which 
happened to be the highest. Adults aged 40 – 59 years 
recorded the prevalence of 25.2%, the age group 
between 60 – 79 years recorded 11.3% prevalence 
while children and adolescents between the age of 0 – 
19 years old had the prevalence 9.5%; adults 80 years 
old and above recorded the least prevalence of 1.0% 
(Table 3) . The sex prevalence results revealed that 
male had the highest prevalence of 93.2% out of 755 
samples studied (i.e 704 positive samples) while 
female had 94.0% prevalence of the 668 samples 
studied (Table 4) (i.e. 628 positive samples). The 
increase on the male prevalence might be due to 
active lifestyles leading to exposure to the aetiologies. 
There was statistical significant difference (p>0.05) in 
the prevalence among male and female subjects 
studied. Different bacteria encountered in this 
research include Staphylococcus aureus, Streptococcus 
pneumonia, Streptococcus pyogenes, Haemophilus 
influenzae, Escherichia coli, Klebsiella pneumoniae, 
Corynebacterium diphtheriae. The adults between the 
ages of 20 – 39 years had the highest prevalence with 
the rate of 46.7%, This high prevalence may be due to 
exposure to recreational activities. The highest 
prevalence of 33.7% recorded by businessmen in the 
social class may be as result of exposure to over 
crowded places during business. The prevalence of 
93.6% in this study is comparatively higher than 6.7% 
prevalence of non - tuberculous mycobacteria in 
bronchiectatic population reported by Guang – Suo et 
al. [9]. Many researchers have undertaken some 
studies on detailed analysis of non – tuberculous 
mycobacteria (NTM). Wickremasinghe et al. [21] 
reported 2% of NTM patients in the context of 
bronchiectasis. Fowler et al. [22] reported 10% of 
prevalence of NTM out of 98 patients in a cohort of 
patients with adult onset of bronchiectasis. The result 
obtained from this study is in agreement with earlier 
report by Pasteur et al. [23] who found low prevalence 
in their studies. Serious emphasis should be laid on 




TABLE 1: DISTRIBUTION OF NON – TUBERCULOUS COUGH AMONG THE HOSPITAL STUDIED 
Hospitals Total Number of Samples AFB-Negative AFB-Positive 
IDHO 548(37.4) 532(97.1) 16(2.9) 
GHC 169(11.5) 158(93.5) 11(6.5) 
GHO 120(8.2) 110(91.7) 108.3) 
GHO 126(8.6) 122(96.8) 4(3.2) 
GHI 250(17.1) 218(87.2) 32(12.8) 
GHB 189(12.9) 178(93.1) 13(6.9) 
GHA 64(4.4) 56(87.5) 8(12.5) 
Total  1466(100) 1372(93.6) 94(6-4) 
 
TABLE 2: SOCIAL CLASS PREVALENCE OF AFB-NEGATIVE CASES IN CROSS RIVER STATE 
 
Location 













IDHO 532 30(5.6) 116(30.3) 156(29.3) 95(17.9) 90(16.9) 
GHC 158 20(12.7) 59(37.3) 16(10.1) 55(34.8) 8(5.1) 
GHO 110 20(18.2) 36(32.7) 28(25.5) 20(18.2) 6(5.5) 
GHU 122 5(4.1) 46(37.7) 50(41.0) 16(13.1) 5(4.1) 
GHI 218 18(8.3) 79(36.2) 74(33.9) 30(13.8) 17(7.8) 
GHB 176 15(8.5) 71(40.3) 44(25.0) 36(20.5) 10(5.7) 
GHA 56 4(7.1) 10(17.9) 23(41.1) 19(33.9) 0(0) 
TOTAL 1372 112(8.2) 462(33.7) 391(28.5) 271(19.8) 136(9.9) 
 
TABLE 3: AGE RELATED PREVALENCE OF NON-TUBERCULOSIS COUGH IN CROSS RIVER STATE 
 
Location 
Total Number of 
Sample 
Age in Years 
0-19 20-39 40-59 60-79 80 and above 
IDHO 548 46(8.4) 226(41.2) 155(28.3) 97(17.7) 8(1.5) 
GHC 169 19(11.2) 103(60.9) 28(16.6) 5(3.0) 3(1.8) 
GHO 120 22(18.3) 43(35.8) 31(25.8) 12(10.0) 2(1.7) 
GHU 126 7(5.6) 81(64.3) 26(20.6) 8(6.3) 0(0) 
GHI 250 20(8.6) 119(47.6) 58(23.2) 21(8.4) 0(0) 
GHB 189 18(19.5) 85(45.0) 52(27.5) 19(10.1) 2(1.1) 
GHA 64 7(10.9) 27(42.2) 19(29.7) 3(4.7) 0(0) 
TOTAL 146 139(9.5) 684(46.7) 369(25.2) 165(11.3) 15(1.0) 
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TABLE 4: PREVALENCE OF NON-TUBERCULOSIS RECURRENT COUGH IN CROSS RIVER STATE BASED ON SEX 
 
Hospitals 
Total No. of 
Samples 
No. of Samples (%) AFB-Negative Case 
Male Female Male (%) Female (%) 
IDHO 548 296(54.0) 252(46.0) 287(97.0) 245(97.2) 
GHC 169 72(42.6) 97(57.4) 65(90.3) 93(95.9) 
GHO 120 69(57.5) 51(42.5) 65(94.2) 45(88.2) 
GHU 126 49(38.9) 77(61.1) 46(93.9) 76(98.7) 
GHI 250 140(56.0) 110(44.0) 123(87.9) 95(90.9) 
GHB 189 99(52.4) 90(47.6) 91(91.9) 85(94.4) 
GHA 64 30(46.9) 34(53.1) 27(90.0) 29(85.3) 
Total  1466 755(51.5) 711(48.5) 704(93.2) 668(94.0) 
 
CONCLUSION                                                                                                                                                                                                     
Cough in the study area originated as a reaction from 
non non – tuberculous infection. The patients’ age 
group 20 – 39 years had the highest prevalence of non 
– tuberculous recurrent cough while the least 
prevalence was among the age group ≥ 80 years. The 
prevalence rate of 33.7% was the highest among the 
social class and businessmen, while the least 
prevalence rate was found among students. There
was statistical significant difference (p>0.05) in the 
prevalence among male and female subjects studied. 
Non – tuberculous prevalence rate of 93.6% was 
observed. Mycobacterium tuberculosis is therefore not 
the predominant cause of cough in the study area as 
at the time of this study. 
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